Results 171 to 180 of about 386,647 (265)
Point-of-care Ultrasound Diagnosed Intraocular Breast Metastasis. [PDF]
Yusuf HM, Batchelor T, Ashenburg N.
europepmc +1 more source
Ovarian Cancer With Breast Metastasis and Two Pathogenic Variants of BRCA1 Gene. [PDF]
Kowsarnia S, Javadi N.
europepmc +1 more source
An introduction for multidrive and environment‐adaptive micro/nanorobotics: design and fabrication strategies, intelligent actuation, and their applications. Various intelligent actuation approaches—magnetic, acoustic, optical, chemical, and biological—can be synergistically designed to enhance flexibility and adaptive behavior for precision medicine ...
Aiqing Ma +10 more
wiley +1 more source
Case report: Diagnostic trap: metastatic endometrial stromal sarcoma with breast metastasis. [PDF]
Tian X, Luo S, Xu T, Wang J.
europepmc +1 more source
Breast Metastasis From Rectal Signet-Ring Cell Carcinoma: A Case Report and Review of Literature. [PDF]
Dai Y +5 more
europepmc +1 more source
Gastric Metastasis from Breast Cancer
So Yoon, Yoon, Ki-Nam, Shim
openaire +2 more sources
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance +17 more
wiley +1 more source
Optimizing Drug Delivery to the Brain for Breast Metastasis: A Novel Method for Tumor Targeting. [PDF]
Krishnamurthy S +4 more
europepmc +1 more source
Breast metastasis from rectal carcinoma: A case report and review of the literature. [PDF]
Wang DD, Yang SJ, Chen WX.
europepmc +1 more source
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He +17 more
wiley +1 more source

